TUV Rheinland OpenSky has helped Insulet’s Omnipod DASH insulin management system to be the first FDA-cleared insulin pump to achieve certification under the Diabetes Technology Society’s cybersecurity assurance standard and program, known as DTSec.
This distinction goes to Insulet Corporation’s Omnipod DASH Insulin Management System.
As the DTSec Accredited Lab, TUV Rheinland OpenSky was engaged to evaluate and test Insulet Corporation’s Omnipod DASH Insulin Management System against the Standard for Wireless Diabetes Device Security (DTSec) Version 2.0.
The evaluation and testing provide users of connected diabetes devices with confidence that the products include the security protections claimed by their developers.
TUV Rheinland OpenSky CEO and president Anish Srivastava said: “In the coming years we expect the proliferation of internet-enabled medical devices. This would drive the convergence of cybersecurity and data privacy with safety. We’re proud to be the DTSec Accredited Lab and a part of the process that helps life-saving devices get to market safely and quickly.”
UCSF Clinical Professor of Medicine and DTSec steering committee Chair David Klonoff said: “Certification per the DTSec Standard demonstrates a commitment to cybersecurity by the manufacturer of this connected wireless insulin pump system. The Omnipod DASH System is part of the Internet of Medical Things and is the first insulin pump system to be DTSec-certified. Diabetes Technology Society commends Insulet Corporation’s dedication to improved safety and security demonstrated by achieving this important milestone.”
Insulet executive vice president and chief technology officer Aiman Abdel-Malek said: “We are highly supportive of DTS’ efforts in pushing commercial best practice guidance for cybersecurity in the connected medical device systems space. We are committed to remaining at the forefront of best-in-class standards for security to ensure patient safety and privacy.”
Source: Company Press Release